The CARMA Technique Study

November 5, 2021 updated by: Alexander Huelsen, Princess Alexandra Hospital, Brisbane, Australia

The Cap-Assisted Resection Margin Assessment (CARMA) Technique After Polyp Resection: a Prospective Feasibility Study of a "Novel" Approach to Reduce Polyp Recurrence

Colonoscopic removal of polyps is an important and well-established tool in the prevention of colorectal cancers. However, high polyp recurrence rates after endoscopic resection, with resultant development of interval cancers, remains a problem; this most commonly stems from unrecognised incomplete polyp resection. Thus, a standardised endoscopic technique is needed that will allow endoscopists to consistently achieve a clear margin of resection. The investigators believe the Cap Assisted Resection Margin Assessment (CARMA) technique will address this problem. This novel technique focuses on a standardised assessment of the resection margin after endoscopic polypectomy utilising available standard high-definition video endoscopes with imaging features including narrow band imaging (NBI) and magnification endoscopy.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Queensland
      • Woolloongabba, Queensland, Australia, 4102
        • Recruiting
        • Princess Alexandra Hospital
        • Contact:
        • Principal Investigator:
          • Alexander Huelsen
        • Sub-Investigator:
          • Zaki Hamarneh
        • Sub-Investigator:
          • Prabha Selvanathan
        • Sub-Investigator:
          • Jennifer Borowsky
        • Sub-Investigator:
          • Caroline Cooper

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Patients with colonic polyps will be considered following below criteria

Inclusion Criteria:

- any polypectomy (though only a maximum of two polyps from one individual participant)

Exclusion Criteria:

  • polyps less than 10mm which were resected under endoscopic view with a definite > 1mm clear margin
  • scar site recurrence polyps
  • polyps with endoscopic evidence of invasion
  • pedunculated polyps
  • pseudopolyps
  • participants who will not be available for follow up endoscopy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CARMA Technique
All included participants undergo polyp resection using standard of care polypectomy techniques, followed by the CARMA technique
Once standard polyp resection and assessment of the polypectomy site without magnification is completed, the CARMA technique will be applied. This will involve an assessment of the entire polypectomy margin using cap assisted magnification endoscopy with the ability to also use NBI (at the endoscopist's discretion) and documentation of any residual polyp noted.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Rate of achieving a clear resection margin using the CARMA technique
Time Frame: Established during index procedure
Established during index procedure

Secondary Outcome Measures

Outcome Measure
Time Frame
Sensitivity and specificity of the CARMA technique for residual polyp detection
Time Frame: Established during index procedure
Established during index procedure
Frequency of residual polyp without CARMA assessment
Time Frame: Established during index procedure
Established during index procedure
Incomplete resection rate with use of CARMA technique
Time Frame: Established during index procedure
Established during index procedure
Incomplete resection rate with use of the CARMA technique in polyps > 10mm with hot snare
Time Frame: Established during index procedure
Established during index procedure
Incomplete resection rate with use of the CARMA technique in polyps > 10mm with cold snare
Time Frame: Established during index procedure
Established during index procedure
Residual polyp rate after CARMA technique with hot snare
Time Frame: Established during index procedure
Established during index procedure
Residual polyp rate after CARMA technique with cold snare
Time Frame: Established during index procedure
Established during index procedure
Time required for application of the CARMA technique with < 10mm
Time Frame: Established during index procedure
Established during index procedure
Time required for application of the CARMA technique with > 10mm
Time Frame: Established during index procedure
Established during index procedure
Polyp recurrence rate for < 10mm polyps
Time Frame: Established during surveillance procedure (following national guidelines - between 6 months to 5 years)
Established during surveillance procedure (following national guidelines - between 6 months to 5 years)
Polyp recurrence rate for > 10mm polyps
Time Frame: Established during surveillance procedure (following national guidelines - between 6 months to 5 years)
Established during surveillance procedure (following national guidelines - between 6 months to 5 years)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alexander Huelsen, MD, Princess Alexandra Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

November 1, 2021

Primary Completion (Anticipated)

May 1, 2023

Study Completion (Anticipated)

November 1, 2026

Study Registration Dates

First Submitted

October 18, 2021

First Submitted That Met QC Criteria

October 18, 2021

First Posted (Actual)

October 29, 2021

Study Record Updates

Last Update Posted (Actual)

November 15, 2021

Last Update Submitted That Met QC Criteria

November 5, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 75076

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colonic Polyp

Clinical Trials on CARMA technique

3
Subscribe